Modified BCG vaccine strengthens protection against TB

Researchers from the Centenary Institute and the University of Sydney have developed a modified version of the tuberculosis (TB) vaccine BCG that provided stronger and more sustained protection against TB. In preclinical ...

B cells may help predict risk of colitis from immunotherapy

Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B cells, adaptive immune cells, in triggering and sustaining colitis as a side effect of immune checkpoint inhibitors, ...

Why repeated exposures may make allergies worse

A new preclinical study led by investigators from Mass General Brigham offers a potential explanation for two longstanding questions in allergy: Why do allergies often emerge only after repeated exposure, and why do people ...

'Plug-and-play' CAR T technology adapts as cancer changes

Researchers from City of Hope have developed a new "plug-and-play" technology that adds engineered molecules to chimeric antigen receptor (CAR) T cells after treatment, allowing scientists to better control the cells and ...

page 3 from 40